Mandate

Vinge advises BHG Group on directed share issue

February 04, 2021 Capital Markets and Public M&A

Vinge advises BHG Group AB (publ) in connection with a directed share issue of approximately SEK 1.6 billion through an accelerated book building procedure, and a coordinated sale of approximately 1.2 million shares as part of the company’s incentive program.

The Vinge team includes Christian Lindhé, Erik Sjöman, Kristian Ford (client responsible partner), Martin Svanberg and Sophia Reutercrona.

Related

Vinge advises Vinci Concessions SAS and its subsidiary SunMind SAS in connection with its acquisition of Helios Nordic Energy AB from Magnora ASA, management and early investors

Helios Nordic Energy specialises in developing solar farms and batteries to store energy until they become Ready to Build in the Nordics and Baltics.
May 30, 2024

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024